We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Nonsurgical Solution Helps Correct Myopia

By HospiMedica International staff writers
Posted on 28 Nov 2013
Print article
Image: The Avedro KXL II System (Photo courtesy of  Avedro).
Image: The Avedro KXL II System (Photo courtesy of Avedro).
A new system uses accelerated photorefractive intrastromal cross-linking (PiXL) procedures for the treatment of myopia and keratoconus.

The KXL II System uses a combination of long ultraviolet (UVA) light waves and riboflavin (vitamin B2) to form cross-linked chemical bonds within the cornea, increasing its rigidity and stability. During the treatment, a photosensitive preparation of ribolflavin eye drops is applied to the cornea, which is then soaked for approximately 60 seconds. The ribolflavin is then dynamized by the UVA rays, a step that lasts for three minutes, during which the riboflavin penetrates the corneal surface by a few microns and induces the lamellae to move closer together.

The KXL II system achieves higher cross-linking speed by increasing UVA power and reducing the exposure time, thereby maintaining the same energy on the eye as standard cross-linking, while reducing cross-linking time by an order of magnitude. The outpatient procedure is noninvasive and painless, lasting for approximately, five minutes per eye from start to finish, compared to the 30 minutes time span required to carry out a standard cross-linking procedure. Another advantage is that it can be repeated later.

An further important advantage of the KXL II accelerated cross-linking system is that unlike the traditional technique, it does not involve removal of the corneal epithelium—the thinnest layer on the outside of the cornea—before administering riboflavin eye drops and UVA light. This allows thinner corneas to be cross-linked with greater precision, potentially decreasing risks and allowing patients outside current treatment criteria to be cross-linked. The KXL II System is a product of Avedro (Boston, MA, USA), and has received the European community CE marking of approval.

“The KXL II and PiXL procedure continue our mission to make refractive correction truly nonsurgical,” said David Muller, PhD, CEO of Avedro. “Treating myopia and other refractive disorders with PiXL has the potential to open up refractive correction to millions of people who have never considered Lasik surgery before, but would consider a nonsurgical alternative.”

“We experienced the amazing capabilities of customized accelerated cross-linking to achieve specific, reproducible, and interim-stable refractive changes on the cornea,” said A. John Kanellopoulos, MD, of the NYU Medical School (NY, USA). “It seems to me that every surgeon who has performed cross-linking has experienced refractive corneal changes. We now have a way to design and customize these refractive changes. If these initial clinical results continue to be repeated, as I believe they will, the potential seems unlimited.”

Related Links:

Avedro


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Anterior Cervical Plate System
XTEND
New
Blood and Infusion Warmer
SW300

Print article
Radcal

Channels

Critical Care

view channel
mage: The electroceutical epidermal patch is designed to inhibit bacterial growth (Photo courtesy of Saehyun Kim/University of Chicago)

Cutting-Edge Bioelectronic Device Offers Drug-Free Approach to Managing Bacterial Infections

Antibiotic-resistant infections pose an increasing threat to patient safety and healthcare systems worldwide. Recent estimates indicate that drug-resistant infections may rise by 70% by 2050, highlighting... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more